GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Quest Laboratories Ltd (NSE:QUESTLAB) » Definitions » Change In Payables And Accrued Expense

Quest Laboratories (NSE:QUESTLAB) Change In Payables And Accrued Expense : ₹0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Quest Laboratories Change In Payables And Accrued Expense?

Quest Laboratories's Change In Payables And Accrued Expense for the quarter that ended in Mar. 2024 was ₹0.0 Mil. It means Quest Laboratories's Accounts Payable & Accrued Expense stayed the same from Dec. 2023 to Mar. 2024 .

Quest Laboratories's Change In Payables And Accrued Expense for the fiscal year that ended in Mar. 2024 was ₹0.0 Mil. It means Quest Laboratories's Accounts Payable & Accrued Expense stayed the same from Mar. 2023 to Mar. 2024 .


Quest Laboratories Change In Payables And Accrued Expense Historical Data

The historical data trend for Quest Laboratories's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Quest Laboratories Change In Payables And Accrued Expense Chart

Quest Laboratories Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Change In Payables And Accrued Expense
- - - -

Quest Laboratories Quarterly Data
Mar21 Mar22 Mar23 Sep23 Dec23 Mar24
Change In Payables And Accrued Expense Get a 7-Day Free Trial - - - - -

Quest Laboratories Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Quest Laboratories Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Quest Laboratories's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Quest Laboratories Business Description

Industry
Traded in Other Exchanges
N/A
Address
Plot No. 45, Sector III, Pithampur Industrial Area, District Dhar, Pithampur, MP, IND, 454775
Quest Laboratories Ltd is engaged in the business of manufacturing pharmaceutical formulations across a broad spectrum, including antibiotics, antimalarials, antispasmodics, anti-inflammatories, antiemetics, respiratory medications, diabetes treatments, antidepressants, and more. It produces various products, comprising ethical drugs, generic drugs, and over-the-counter drugs, and is also available in various forms such as tablets, liquid orals, oral dry powders, oral powders (ORS), ointments, and external liquids.

Quest Laboratories Headlines

No Headlines